UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 22, 2003
CHAD THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
| | | | | |
| California | | 001-12214 | | 34-1659805 |
| |
| |
|
(State or other jurisdiction
of incorporation) | | (Commission
File Number) | | (IRS Employer
Identification No.) |
| | | | | |
| 21622 Plummer Street, Chatsworth, California | | | 91311 | |
| | |
| |
| (Address of principal executive offices) | | | (Zip Code) | |
Registrant’s telephone number, including area code: (818) 882-0883
Not Applicable
(Former name or former address, if changed since last report.)
TABLE OF CONTENTS
ITEM 9. REGULATION FD DISCLOSURE (INFORMATION PROVIDED UNDER ITEM 12 – RESULTS OF OPERATIONS AND FINANCIAL CONDITION)
Pursuant to Securities and Exchange Commission Release No. 33-8216 dated March 27, 2003, the following information is being furnished under Item 12 of Form 8-K.
On May 22, 2003, CHAD Therapeutics issued a press release announcing its fourth quarter and fiscal 2003 operating results. A copy of the press release is furnished herewith as Exhibit 99.1 to this Report.
[Remainder of Page Left Intentionally Blank.]
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | CHAD THERAPEUTICS, INC.,
a California corporation |
| | | | | |
| Date: May 23, 2003 | | By | | /s/ Earl L. Yager
Earl L. Yager
President, Chief Financial
Officer, and Chief Operating Officer |
3
